Sous-titre

DELPRAT Benjamin

Laboratory research grant - 2019

Contenu
Body

Project status: active

Wolfram syndrome is a rare neurodegenerative disease leading to optic atrophy, hearing loss and diabetes. Other symptoms may also be present. This form of hereditary optic atrophy is very severe, as patients die at around the age of 35 of respiratory distress or pulmonary aspiration. Unfortunately, no medication currently exists.

The need to find a treatment is therefore urgent. Since Wolfram syndrome is a pathology affecting several organs, small active molecules could be used to effectively treat all the symptoms. Interestingly, zebrafish have become powerful tools for discovering new effective drugs for humans.

The objective of Dr. Delprat's project is to use a mutant zebrafish model for the gene responsible for Wolfram syndrome. This model, which develops visual and auditory deficits similar to those observed in patients, will make it possible to test a panel of effective molecules capable of slowing or stopping the disease, and open up prospects for a rapid clinical transfer to humans.

Doctor Benjamin Delprat
“Molecular Mechanisms in Neurodegenerative Dementia,” Montpellier University, France

Related scientific publication(s):